Identifying potential biological processes and key targets in COVID-19-associated heart failure

Novel coronavirus pneumonia (COVID-19) is a new type of viral pneumonia caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has spread rapidly and become a global pandemic. Heart failure (HF) is the ultimate period of the development of various cardiovascular diseases. There are several research have found that SARS-CoV-2 infection may induce cardiac complications including enhanced cardiac stress biomarkers and heart failure. Our research aims at identifying underlying biological processes and key targets in COVID-19associated heart failure via bioinformatics analysis. A total of three heart failure datasets and three COVID-19 datasets were obtained using the Gene Expression Omnibus (GEO) database. Batch effects cross each sample were eliminated with surrogate variable analysis algorithm. Then, we identified key modules of COVID-19 datasets and heart failure datasets through weighted gene co-expression network analysis. HF-associated as well as COVID-19-associated key modules were intersected for determining the shared genes of COVID-19-associated heart failure. The pivotal genes associated with COVID-19-related heart failure were determined by intersecting the shared genes with the HF-associated hub genes selected through WGCNA. Furthermore, we conducted GO as well as KEGG enrichment analysis on shared genes of COVID-19-associated heart failure. Two COVID-19-associated key modules as well as three HF-associated key modules were determined. In addition, eleven shared genes for COVID-19-associated heart failure were determined. In conclusion, our work screened two critical genes, namely PYGM and BLM, which may be possible intervention targets for COVID-19-associated heart failure. According to functional enrichment results, the shared genes of COVID-19-associated heart failure showed high enrichment in starch and sucrose metabolism, homologous recombination, Fanconi anemia pathway, and insulin resistance indicate the probably biological processes linked to COVID-19-associated heart failure. These results provided further insights in possible interventional and therapeutic targets of COVID-19-associated heart failure.